A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study is an open‐label, multicenter Phase IB/II clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR‐A2009 for injection in combination with other antitumor therapies in patients with advanced solid tumors.
Epistemonikos ID: b86b8c5ba82417c91d3ae42c77d66c71a1851e4d
First added on: May 15, 2024